(-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor

British Journal of Pharmacology

Volumn 117, Issue 1, 1996, Pages 93-98

  Kaumann, Alberto J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

( ) CGP 12177; Antagonism by ( ) bupranolol; Human atrium; Positive inotropic effects; 3 adrenoceptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA 3 ADRENERGIC RECEPTOR; BUPRANOLOL; CALCIUM CHLORIDE; ISOPRENALINE; PROPRANOLOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM CONTRACTION; HEART FAILURE; HEART MUSCLE CONTRACTILE FORCE; HUMAN; HUMAN TISSUE; INOTROPISM; MALE; OPEN HEART SURGERY; PRIORITY JOURNAL; RECEPTOR BLOCKING;

EID: 0030030731     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15159.x     Document Type: Article

References (36)

1. 3 and atypical β-adrenoceptors. Med. Res. Rev., 14, 663-729.
2. 3-adrenoceptor: structure-activity relationship of β-adrenergic ligands. Mol. Pharmacol., 44, 1094-1104.
3. 3-adrenoceptor. Br. J. Pharmacol., 112, 911-919.
4. BLINKS, J.R. (1965). Convenient apparatus for recording contractions of isolated muscle. J. Appl. Physiol., 20, 755-757.
5. BLINKS, J.R. (1966). Field stimulation as a means of effecting the graded release of autonomie transmitters in isolated heart muscle. J. Pharmacol. Exp. Ther., 151, 221-235.
6. BLINKS, J.R. (1967). Evaluation of the cardiac effects of several beta adrenergic blocking agents. Ann. New York Acad. Sci., 139, 673-685.
7. 3-adrenoceptor refractory to down-regulation. Biochem. J., 303, 973-978.
8. 3-adrenergic receptor. J. Pharmacol. Exp. Ther., 271, 1253-1258.
9. 3-adrenoceptor. Science, 245, 1118-1121.
10. 2-adrenoceptors of human heart. Differentiation of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn-Schmied. Arch. Pharmacol., 331, 60-70.
11. GRANNEMAN, J.G. (1992). Effects of agonist exposure on the coupling of beta1 and beta3 adrenergic receptors to adenylyl cyclase in isolated adipocytes. J. Pharmacol. Exp. Ther., 261, 638-642.
12. 3-adrenoceptor messenger ribonucleic acid. Endocrinology, 135, 1025-1031.
13. 3-adrenergic receptor gene. Mol. Pharmacol., 44, 264-270.
14. 2-adrenoceptors in human atrial myocardium. Circ. Res., 66, 1610-1623.
15. HARMS, H.H., ZAAGSMA, J. & DE VENTE, J. (1977). Differentiation of β-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat using stereoisomers of propranolol, alprenolol, nifenalol and practolol. Life Sci., 21, 123-128.
16. KAUMANN, A.J. (1973). Adrencrgic receptors in heart muscle. Two different mechanisms of β blockers as partial agonists. International Union of Biochemistry, Symposium 52, Acta Physiol. Latamer., 23, 235-236.
17. KAUMANN, A.J. (1983). Cardiac β-adrenoceptors. Experimental viewpoints. Z. Kardiol., 72, 63-82.
18. KAUMANN, A.J. (1989). Is there a third heart β-adrenoceptor Trends Pharmacol. Sci., 10, 316-320.
19. KAUMANN, A.J. & BLINKS, J.R. (1980). β-Adrenoceptor blocking agents as partial agonists in isolated heart muscle. Dissociation of stimulation and blockade. Naunyn-Schmied. Arch. Pharmacol., 311, 237-248.
20. KAUMANN, A.J. & LOBNIG, B.M. (1986). Mode of action of (-)-pindolol on feline and human myocardium. Br. J. Pharmacol., 89, 207-218.
21. 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur. Heart J., 10 (Suppl. B), 29-37.
22. 2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium. Naunyn-Schmied. Arch. Pharmacol., 348, 536-540.
23. 4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockade. Naunyn-Schmied. Arch. Pharmacol., 349, 331-337.
24. 2 receptor system of human atrium. Naunyn-Schmied. Arch. Pharmacol., 351, R114.
25. 3-adrenergic receptor mRNA in man. J. Clin. Invest., 91, 344-349.
26. LANGIN, D., PORTILLO, M.P., SAULNIER-BLACHE, J.-S. & LAFONTAN, M. (1991). Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol., 199, 291-301.
27. 2-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A., 90, 3665-3669.
28. 3-adrenoceptor in man. Br. J. Pharmacol., 110, 929-936.
29. MAN IN'T VELD, A.J. & SCHALEKAMP, M.A.D.H. (1981). Pindolol acts as a beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications. Br. Med. J., 282, 929-931.
30. 3-adrenergic receptor is resistant to short-term agonist-promoted desensitization. Mol. Pharmacol., 43, 548-555.
31. 3-adrenoceptor signalling. Br. J. Pharmacol., 114, 1045-1051.
32. 3-adrenergic receptor in human white adipose tissue. J. Mol. Endocrinol., 10, 193-197.
33. 4 receptors by chronic β blocker treatment. Circulation, 92, 2526-2539.
34. 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol. Pharmacol., 43, 343-348.
35. WALTER, M., LEMOINE, H, & KAUMANN, A.J. (1984). Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node und trachea of guinea pig: role of β-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn-Schmied. Arch. Pharmacol., 327, 159-175.
36. 3-adrenoceptor agonist BRL 35135 in man. Br. J. Clin. Pharmacol., 37, 363-369.